Expression, purification and crystallization of adenosine 1408 aminoglycoside-resistance rRNA methyltransferases for structural studies
- PMID: 20667473
- PMCID: PMC2966526
- DOI: 10.1016/j.pep.2010.07.005
Expression, purification and crystallization of adenosine 1408 aminoglycoside-resistance rRNA methyltransferases for structural studies
Abstract
High-level resistance to a broad spectrum of aminoglycoside antibiotics can arise through either N7-methyl guanosine 1405 (m⁷G1405) or N1-methyl adenosine 1408 (m¹A1408) modifications at the drug binding site in the bacterial 30S ribosomal subunit decoding center. Two distinct families of 16S ribosomal RNA (rRNA) methyltransferases that incorporate these modifications were first identified in aminoglycoside-producing bacteria but were more recently identified in both human and animal pathogens. These resistance determinants thus pose a new threat to the usefulness of aminoglycosides as antibiotics, demanding urgent characterization of their structures and activities. Here, we describe approaches to cloning, heterologous expression in Escherichia coli, and purification of two A1408 rRNA methyltransferases: KamB from the aminoglycoside-producer Streptoalloteichus tenebrarius and NpmA identified in a clinical isolate of pathogenic E. coli ARS3. Antibiotic minimum inhibitory concentration (MIC) assays and in vitro analysis of KamB and NpmA using circular dichroism (CD) spectroscopy, S-adenosyl-l-methionine (SAM) binding by isothermal titration calorimetry and 30S subunit methylation assays showed both enzymes were soluble, folded and active. Finally, crystals of each enzyme complexed with SAM were obtained, including selenomethionine-derived KamB, that will facilitate high-resolution X-ray crystallographic analyses of these important bacterial antibiotic-resistance determinants.
Copyright © 2010 Elsevier Inc. All rights reserved.
Figures




Similar articles
-
Structural insights into the function of aminoglycoside-resistance A1408 16S rRNA methyltransferases from antibiotic-producing and human pathogenic bacteria.Nucleic Acids Res. 2010 Nov;38(21):7791-9. doi: 10.1093/nar/gkq627. Epub 2010 Jul 17. Nucleic Acids Res. 2010. PMID: 20639535 Free PMC article.
-
Expansion of the aminoglycoside-resistance 16S rRNA (m(1)A1408) methyltransferase family: expression and functional characterization of four hypothetical enzymes of diverse bacterial origin.Biochim Biophys Acta. 2014 Sep;1844(9):1648-55. doi: 10.1016/j.bbapap.2014.06.012. Epub 2014 Jun 22. Biochim Biophys Acta. 2014. PMID: 24963996 Free PMC article.
-
Methylation of immature small ribosomal subunits by methyltransferases conferring aminoglycoside resistance.Arch Biochem Biophys. 2025 Jul;769:110422. doi: 10.1016/j.abb.2025.110422. Epub 2025 Apr 11. Arch Biochem Biophys. 2025. PMID: 40221015
-
Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: an update.Drug Resist Updat. 2012 Jun;15(3):133-48. doi: 10.1016/j.drup.2012.05.001. Epub 2012 Jun 4. Drug Resist Updat. 2012. PMID: 22673098 Review.
-
Aminoglycoside Resistance: Updates with a Focus on Acquired 16S Ribosomal RNA Methyltransferases.Infect Dis Clin North Am. 2020 Dec;34(4):887-902. doi: 10.1016/j.idc.2020.06.002. Epub 2020 Sep 30. Infect Dis Clin North Am. 2020. PMID: 33011054 Free PMC article. Review.
Cited by
-
30S Subunit-dependent activation of the Sorangium cellulosum So ce56 aminoglycoside resistance-conferring 16S rRNA methyltransferase Kmr.Antimicrob Agents Chemother. 2015 May;59(5):2807-16. doi: 10.1128/AAC.00056-15. Epub 2015 Mar 2. Antimicrob Agents Chemother. 2015. PMID: 25733511 Free PMC article.
-
Molecular recognition and modification of the 30S ribosome by the aminoglycoside-resistance methyltransferase NpmA.Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6275-80. doi: 10.1073/pnas.1402789111. Epub 2014 Apr 9. Proc Natl Acad Sci U S A. 2014. PMID: 24717845 Free PMC article.
-
Discovery of First-in-Class Inhibitors Targeting a Pathogen-Associated Aminoglycoside-Resistance 16S rRNA Methyltransferase.ACS Infect Dis. 2025 Aug 8;11(8):2276-2286. doi: 10.1021/acsinfecdis.5c00297. Epub 2025 Jul 11. ACS Infect Dis. 2025. PMID: 40643688 Free PMC article.
-
The Pathogen-Derived Aminoglycoside Resistance 16S rRNA Methyltransferase NpmA Possesses Dual m1A1408/m1G1408 Specificity.Antimicrob Agents Chemother. 2015 Dec;59(12):7862-5. doi: 10.1128/AAC.01872-15. Epub 2015 Sep 28. Antimicrob Agents Chemother. 2015. PMID: 26416864 Free PMC article.
-
16S rRNA Methyltransferases as Novel Drug Targets Against Tuberculosis.Protein J. 2022 Feb;41(1):97-130. doi: 10.1007/s10930-021-10029-2. Epub 2022 Feb 3. Protein J. 2022. PMID: 35112243 Review.
References
-
- Jana S, Deb JK. Molecular understanding of aminoglycoside action and resistance. Appl. Microbiol. Biotechnol. 2006;70:140–150. - PubMed
-
- Cundliffe E. How antibiotic-producing organisms avoid suicide. Annu. Rev. Microbiol. 1989;43:207–233. - PubMed
-
- Long KS, Vester B. Resistance to antibiotics in bacteria through modification of nucleosides in 23S ribosomal RNA. In: Grosjean H, editor. DNA and RNA Modification Enzymes: Comparative Structure, Mechanism, Functions, Cellular Interactions and Evolution. Austin, TX: Landes Bioscience; 2009.
-
- Conn GL, Savic M, Macmaster R. Resistance to antibiotics in bacteria through modification of nucleosides in 16S ribosomal RNA. In: Grosjean H, editor. DNA and RNA Modification Enzymes: Comparative Structure, Mechanism, Functions, Cellular Interactions and Evolution. Austin, TX: Landes Bioscience; 2009.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical